Koers Aceragen, Inc. Nyse
Aandelen
ACGN
US00445F1093
Biotechnologie & Medisch Onderzoek
Omzet 2021 | - | Omzet 2022 | 4,86 mln. 4,55 mln. | Marktkapitalisatie | 3,12 mln. 2,92 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 98 mln. 91,66 mln. | Nettowinst (verlies) 2022 | -23 mln. -21,51 mln. | EV/omzet 2021 * | - |
Nettoliquiditeiten 2021 * | - 0 | Nettoliquiditeiten 2022 * | - 0 | EV/omzet 2022 * | - |
K/w-verhouding 2021 * |
-
| K/w-verhouding 2022 * |
-
| Werknemers | 26 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 * |
-
| Vrij verhandelbaar | 38,12% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,21% | 43,43 mld. | |
+49,05% | 41,69 mld. | |
+9,73% | 41,31 mld. | |
-10,82% | 27,14 mld. | |
+10,57% | 25,28 mld. | |
-23,76% | 18,47 mld. | |
+36,75% | 12,59 mld. | |
+3,33% | 12,33 mld. | |
+8,48% | 11,03 mld. |